File Justin J. has filed 5 insider transactions across 2 companies since December 2022.
Most recent transaction: a grant/award of 455000 shares of Lite Strategy, Inc. ($LITS) on February 12, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | Lite Strategy, Inc. | $LITS | File Justin J. | CEO, CFO and Secretary | A | Stock Option (Right to Buy) | 455000 | $0.00 | 635,000.0000 | 37,372,000 | 252.78% | 1.22% |
| Nov. 14, 2025 | Lite Strategy, Inc. | $LITS | File Justin J. | CEO, CFO and Secretary | A | Stock Option (Right to Buy) | 180000 | $0.00 | 180,000.0000 | 36,785,397 | 9999.99% | 0.49% |
| Nov. 14, 2025 | Lite Strategy, Inc. | $LITS | File Justin J. | CEO, CFO and Secretary | A | Stock Option (Right to Buy) | 635000 | $0.00 | 635,000.0000 | 36,785,397 | 9999.99% | 1.73% |
| July 15, 2025 | Lite Strategy, Inc. | $LITS | File Justin J. | Secretary, Acting CEO & CFO | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 6,663,000 | 9999.99% | 0.30% |
| Dec. 31, 2022 | Evofem Biosciences, Inc. | $EVFM | File Justin J. | Chief Financial Officer | D | Common Stock | 30000 | $0.00 | 24,065.0000 | 0 | 55.49% | 0.00% |